Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00225212
What this trial is testing

Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaDiffuse Large Cell LymphomaMantle Cell Lymphoma+3 more
Stanford University 35
Early research (Phase 1)Study completedNCT02482311
What this trial is testing

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

Who this might be right for
Ovarian Cancer, TNBC, SCLC, Other Solid Tumours
AstraZeneca 92
Testing effectiveness (Phase 2)Study completedNCT00514267
What this trial is testing

An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors

Who this might be right for
Prostate CancerTumors
Astellas Pharma Inc 32
Testing effectiveness (Phase 2)Looking for participantsNCT05144698
What this trial is testing

RAPA-201 Therapy of Solid Tumors

Who this might be right for
Solid TumorSmall Cell and Non-small Cell Lung CancerHead and Neck Cancer+6 more
Rapa Therapeutics LLC 37
Testing effectiveness (Phase 2)Looking for participantsNCT07692204
What this trial is testing

A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerOesophageal Carcinoma
Sanofi 30
Large-scale testing (Phase 3)Study completedNCT02634931
What this trial is testing

Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex

Who this might be right for
Tuberous SclerosisAngiofibromaHypomelanotic Macule+1 more
Nobelpharma 94
Early research (Phase 1)Study completedNCT00012181
What this trial is testing

Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas

Who this might be right for
Recurrent Childhood Brain Stem GliomaRecurrent Childhood Cerebellar AstrocytomaRecurrent Childhood Cerebral Astrocytoma+19 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Not Yet RecruitingNCT07809906
What this trial is testing

Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 Expression

Who this might be right for
CD123+ Acute Myeloid Leukemia
Orum Therapeutics USA, Inc. 42
Testing effectiveness (Phase 2)Looking for participantsNCT06112704
What this trial is testing

HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Hansoh BioMedical R&D Company 220
Early research (Phase 1)Looking for participantsNCT06789198
What this trial is testing

Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA

Who this might be right for
Fibrolamellar Hepatocellular Carcinoma (FLC)
University Hospital Tuebingen 20
Not applicableLooking for participantsNCT06177106
What this trial is testing

SUV PDL1/PD1 in Sun Damaged & Sun Protected Human Skin of Participants

Who this might be right for
Other Skin Changes Due to Chronic Exposure to Nonionizing Radiation
University of Arizona 46
Early research (Phase 1)Study completedNCT00606645
What this trial is testing

Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma

Who this might be right for
Hodgkin LymphomaAnaplastic Large Cell Lymphoma
Xencor, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT05007106
What this trial is testing

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

Who this might be right for
Uterine Cervical NeoplasmsEndometrial NeoplasmsSquamous Cell Carcinoma of Head and Neck+8 more
Merck Sharp & Dohme LLC 613
Early research (Phase 1)Study completedNCT00660920
What this trial is testing

Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies

Who this might be right for
Chronic Myelogenous LeukemiaHematologic Malignancies
Ariad Pharmaceuticals 81
Early research (Phase 1)Study completedNCT00635778
What this trial is testing

A Dose-finding Study of Dalotuzumab in Subjects With Advanced Solid Tumors (MK-0646-002)

Who this might be right for
Advanced Solid Tumors
Merck Sharp & Dohme LLC 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06035497
What this trial is testing

Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

Who this might be right for
Relapsed or Refractory T-cell Lymphomas
Bristol-Myers Squibb 85
Not applicableUnknownNCT04256720
What this trial is testing

The Multi-Ethnic Lifestyle Study

Who this might be right for
Diabetes MellitusChronic Kidney DiseasesCardiovascular Diseases+7 more
University of Leicester 9,500
Testing effectiveness (Phase 2)Looking for participantsNCT01639508
What this trial is testing

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

Who this might be right for
Non-Small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 86
Not applicableLooking for participantsNCT07372508
What this trial is testing

Glasgow Low-dose CT and AI-based Diagnostics to Case Find Lung Cancer and Other Cardio-respiratory Long-term Conditions - Feasibility Study

Who this might be right for
Cancer
NHS Greater Glasgow and Clyde 500
Testing effectiveness (Phase 2)Looking for participantsNCT06474455
What this trial is testing

A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd. 156
Next Page